Top compounds associated with response to SMG9


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA BMS-708163 GDSC1000 pan-cancer AAC -0.11 0.002
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA MGCD-265 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA JNK-9L GDSC1000 pan-cancer AAC -0.11 0.002
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.11 0.003
mRNA KIN001-055 GDSC1000 pan-cancer AAC -0.1 0.003
mRNA TKI258 CCLE pan-cancer AAC 0.14 0.003
Download CSV